SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-038958
Filing Date
2020-06-25
Accepted
2020-06-25 17:44:15
Documents
2
Period of Report
2020-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4073
2 POA DOCUMENT poa.txt EX-24.4_924608 4276
  Complete submission text file 0001209191-20-038958.txt   9824
Mailing Address C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Carter Eric G (Reporting) CIK: 0001387660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 20990297

Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)